H.B. Fuller stock faces USD 950 million debt funding for AMS deal

Published on 10/08/2026 at 01:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

H.B. Fuller stock was trading at USD 50.11 on October 7, 2026, down 1.03 percent from the prior close. Q3 diluted EPS reached USD 1.44, while adjusted EPS was USD 1.52.

FUL, US3596941068, Illustration mit AI erstellt.

H.B. Fuller (ISIN US3596941068) was trading at USD 50.11 on the NYSE on October 7, 2026, at 1:40 p.m. ET, down 1.03 percent from the prior close of USD 50.63. The company had launched USD 950 million of senior unsecured notes on October 6 to help finance its planned acquisition of Advanced Medical Solutions Group plc.

Debt funds the AMS acquisition

According to StockTitan on October 6, 2026, H.B. Fuller will use the notes, cash and other borrowings for the AMS purchase, transaction costs, certain AMS debt and the repayment of existing borrowings.

The filing also sets a clear financing risk marker. If the acquisition is not completed by June 25, 2027, subject to an extension, H.B. Fuller must redeem USD 450 million of the notes at par plus accrued interest, according to StockTitan.

Quarterly growth supports the case

H.B. Fuller reported USD 938.2 million in Q3 2026 revenue for the three months ended August 29, 2026, up 5.2 percent from the prior-year quarter. Net income rose to USD 79.2 million from USD 67.2 million, while diluted EPS increased to USD 1.44 from USD 1.22, according to StockTitan.

The adjusted view was stronger. MarketBeat reported adjusted EPS of USD 1.52 for Q3, above the USD 1.47 consensus, while adjusted EBITDA rose 9 percent to USD 187 million and the adjusted EBITDA margin reached 19.9 percent.

Analyst target stays above the stock

MarketBeat reported a Moderate Buy consensus from eight analysts on October 4, 2026. Four analysts rated the shares Buy, three rated them Hold and one assigned Strong Buy, with an average 12-month target of USD 64.62.

That average target lies 29.0 percent above the USD 50.11 price. Credit risk adds a counterweight: Fitch Ratings assigned the new notes a BB rating and said the AMS transaction would create a moderate leverage step-up.

Stock remains below its yearly high

At USD 50.11 on October 7, 2026, H.B. Fuller stock stood 27.0 percent below its 52-week high of USD 68.63 and above its 52-week low of USD 46.70. The USD 2.7 billion market capitalization places the financing decision alongside a measurable valuation gap.